David Brennan

Alexion

Pharma

How Alexion's asking AZ to up its offer almost cost it a deal

A surprising tax scrutiny almost derailed deal talks between Alexion and AstraZeneca ahead of their proposed $39 billion merger.

Angus Liu Apr 14, 2021 11:38am

Soliris

Alexion says top brass pressured staff to pad Soliris sales

Jan 5, 2017 9:26am

Soliris

Emergency Alexion chief Brennan says he's '120% committed'

Dec 13, 2016 11:15am